I'm Dr. Rafaella A. Gonçalves, neuroscientist and founder of CognoWise. I have over 10 years of experience in biomedical research and medical writing, and I help universities, companies, and researchers create high-quality, evidence-based materials.
Specialized services tailored to your specific needs
Professional, accurate, evidence-based content that communicates complex medical and scientific topics with clarity and impact.
Expert scientific editing to elevate your work to publication-ready standards.
Bringing neuroscience and medical expertise to test and refine healthcare-focused language models.
Specialized support at every stage of biomedical research, from concept to application.
Nuanced translation of technical documents accross multiple languages, preserving scientific accuracy.
Tailored services designed specifically for your project's challenges.
Below are examples of my peer-reviewed publications.
For a full list, visit my Google Scholar.
Nature Reviews Neuroscience | 2022 | Impact Factor: 28.7
Comprehensive review highlighting how disrupted insulin signaling and metabolic stress contribute to cognitive decline in Alzheimer’s disease. A key reference for understanding the metabolic underpinnings of neurodegeneration.
Neuropharmacology | 2021 | Impact Factor: 4.6
Review article summarizing evidence of how blood-borne molecules reach the brain and how this knowledge can guide the development of minimally invasive drug delivery methods for neurological disorders.
Frontiers in Cellular Neuroscience | 2019 | Impact Factor: 4.0
This review highlights how pathological tau disrupts insulin signaling in the brain and body, creating a cycle that links Alzheimer’s disease with metabolic dysfunction. Understanding this tau-insulin connection could open new therapeutic opportunities.
Alzheimer's & Dementia | 2023 | Impact Factor: 14.5
Research paper identifying the hormone irisin as a biomarker linking depression and dementia in elderly individuals, highlighting its clinical potential for disease diagnosis and therapeutic intervention.
Translational Psychiatry | 2021 | Impact Factor: 7.0
Research paper demonstrating how elevated interleukin-6 (IL-6) levels may drive both metabolic disturbances and memory loss in Alzheimer’s disease, reinforcing the inflammatory link to cognitive decline.
Frontiers in Endocrinology | 2020 | Impact Factor: 4.6
This study reveals that tau protein helps regulate memory, mood, and metabolism in mice. Loss of tau caused anxiety and memory issues, while adding human tau worsened metabolic dysfunction, highlighting complex roles for tau in Alzheimer’s models.
I'm Dr. Rafaella A. Gonçalves, a neuroscientist with over 10 years of experience in both academic and private sectors.
After earning my PhD at Queen's University in Canada and completing postdoctoral research at the Gladstone Institutes/UCSF in the United States, I now leverage my deep bench-to-publication expertise to help healthcare companies and research teams translate complex data into clear, high-impact content.
PhD in Neuroscience, Queen's University (2022)
MSc in Medical Biochemistry, University of Toronto & UFRJ (2017)
Aging, Neurology, Biochemistry, Metabolism, Behavior, AI in medicine, Cardiology, Dermatology
Medical writing, Data Analysis (R, SPSS, GraphPad Prism, Python), Evidence synthesis, AI
With a PhD and 10+ years of biomedical research experience, I bring rigorous, credible subject-matter expertise to every project.
I understand academic and industry demands, delivering solutions on time without compromising on quality.
I translate complex scientific data into clear, tailored messages for grants, publications, and stakeholders.
Every project is unique, and so is my approach. As an independent consultant, I deliver client-focused, customized solutions.
Ready to discuss your project? Contact me today for a free consultation.
rafaella@cognowise.ca
Ottawa, ON, Canada (available worldwide)